Drug-induced endocrine blood pressure elevation

Katharina R. Beck, George Richard Thompson, Alex Odermatt

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.

Original languageEnglish (US)
Article number104311
JournalPharmacological Research
DOIs
StatePublished - Jan 1 2019

Fingerprint

Blood Pressure
Hypertension
Pharmaceutical Preparations
Product Recalls and Withdrawals
Mineralocorticoid Receptors
Endocrine System
Steroids
Therapeutics

Keywords

  • 11beta-hydroxysteroid dehydrogenase
  • Abiraterone
  • Adverse drug reaction
  • Carbenoxolone
  • Catecholamine
  • Danazol
  • Etomidate
  • Hypertension
  • Itraconazole
  • Ketoconazole
  • Lisdexamphetamine
  • Metyrapone
  • Mifepristone
  • Mineralocorticoid excess
  • Posaconazole
  • Steroidogenesis

ASJC Scopus subject areas

  • Pharmacology

Cite this

Drug-induced endocrine blood pressure elevation. / Beck, Katharina R.; Thompson, George Richard; Odermatt, Alex.

In: Pharmacological Research, 01.01.2019.

Research output: Contribution to journalReview article

@article{df6c46c5d7ab44d587753c482737d0b4,
title = "Drug-induced endocrine blood pressure elevation",
abstract = "Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.",
keywords = "11beta-hydroxysteroid dehydrogenase, Abiraterone, Adverse drug reaction, Carbenoxolone, Catecholamine, Danazol, Etomidate, Hypertension, Itraconazole, Ketoconazole, Lisdexamphetamine, Metyrapone, Mifepristone, Mineralocorticoid excess, Posaconazole, Steroidogenesis",
author = "Beck, {Katharina R.} and Thompson, {George Richard} and Alex Odermatt",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.phrs.2019.104311",
language = "English (US)",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Drug-induced endocrine blood pressure elevation

AU - Beck, Katharina R.

AU - Thompson, George Richard

AU - Odermatt, Alex

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.

AB - Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.

KW - 11beta-hydroxysteroid dehydrogenase

KW - Abiraterone

KW - Adverse drug reaction

KW - Carbenoxolone

KW - Catecholamine

KW - Danazol

KW - Etomidate

KW - Hypertension

KW - Itraconazole

KW - Ketoconazole

KW - Lisdexamphetamine

KW - Metyrapone

KW - Mifepristone

KW - Mineralocorticoid excess

KW - Posaconazole

KW - Steroidogenesis

UR - http://www.scopus.com/inward/record.url?scp=85067503754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067503754&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2019.104311

DO - 10.1016/j.phrs.2019.104311

M3 - Review article

AN - SCOPUS:85067503754

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

M1 - 104311

ER -